# SCRIMED p.33 Implementation Status

Status: implementation and local validation complete; exact-candidate independent human review pending.

## Implemented

- Clinical Context Fabric v2 with source spans, temporal events, coreference, terminology, medication/problem relationships, tenant isolation, revocation, purpose limits, compression, and deterministic invalidation.
- Fail-closed Clinical Extraction Release Gate and synthetic FHIR, OMOP, OpenEHR, typed MCP, and offline terminology contracts.
- Append-only Decision Evidence Ledger with chain verification, affected-object lookup, and permitted replay metadata.
- Regulatory Label Twin and Oversight Drift Sentinel.
- Independent Agentic Change Management review packets.
- Portable agent task/result envelopes, qualified routing, local-worker admission, and emergency revocation.
- Synthetic Trace-to-Eval Foundry and ClinicalTrajectory evaluation.
- Ten feature-flagged opportunity modules with typed services and operational KPIs.
- Three explicit pilot profiles with non-bypassable PHI/Linux restrictions.
- G21-G25 continuous-assurance gates, exact action approval binding, independent failover checks, quality ratchet, value contract, and five distinct readiness decisions.
- Integrated p.33 control-plane APIs, Product Console linkage, navigation, responsive UI, documentation, tests, and deterministic artifacts.
- Continuous-assurance API at `/api/scrimed-control-plane/p33/assurance` and operator-facing p.33 console coverage.
- Maintainable, evidence-bound 12-slide investor-deck source and claim manifest.

## Local Validation Evidence

- Deterministic p.33 domain validation: 17/17 checks passed.
- Focused p.33 policy and contract validation: 30/30 policy checks and 25/25 integration checks passed.
- Local control-plane API coverage: seven logical p.33 endpoints, including continuous assurance.
- Product Console response: 775,065 bytes; no full domain payload was added to its compact surface.
- Desktop and 390px browser checks: no horizontal overflow and no console warnings.
- Production build: 627 routes and 460 static pages; exact build ID is emitted by final candidate validation rather than frozen in source documentation.
- Rendered investor deck: 12 slides; strict review and overflow review passed; SHA-256 `b042b32834de48bceb337d8b33fe14242ca7bff8869722ca41e096b75999b4b9`.
- SBOM: 422 components and zero dependency or lockfile delta. Final candidate tooling must recompute exact release fingerprints after the local commit.

The local shell did not expose `npm`; validation used the repository's Node 24 runtime and the repository's direct-Node quality runner. This is an environment-path limitation, not a bypass of the underlying checks.

## Retained Boundaries

No live PHI, autonomous clinical care, diagnosis, treatment, prescribing, triage, coverage decision, payer submission, claims submission, EHR writeback, external outreach, provider call, deployment, migration, customer activation, certification claim, or external distribution is authorized.

## External Gates

Independent technical, clinical-safety, claims/legal, security/privacy, platform, founder/counsel/finance, database-owner, AAL2 operator, Supabase owner, Vercel owner, release-owner, and customer-specific authority remain external. See `artifacts/p33/P33_GATE_MATRIX.json`.
